Alpha Teknova (TKNO) Return on Capital Employed (2021 - 2026)
Alpha Teknova (TKNO) posted quarterly Return on Capital Employed of 17.31% for Q1 2026, up 384.0% year-over-year from 3.58% in Q1 2025, and little changed quarter-over-quarter from 17.31% in Q4 2025.
Alpha Teknova (TKNO) Return on Capital Employed (2021 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has reported Return on Capital Employed for 6 consecutive years, with 17.31% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Capital Employed rose 384.0% year-over-year to 17.31%; the TTM figure through Mar 2026 stood at 17.31% (up 384.0% YoY), while the FY2025 annual figure was 16.38%, up 687.0% from the prior year.
- Return on Capital Employed was little changed at 17.31% in Q1 2026 per TKNO's latest filing, from 17.31% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 10.47% in Q1 2022 and bottomed at 49.14% in Q2 2023.
- Historically, Return on Capital Employed has averaged 25.51% across 5 years, with a median of 25.29% in 2022.
- Annual changes were most pronounced in 2023 — Return on Capital Employed tumbled 3680 bps — and 2024, when it surged 1958 bps.
- Alpha Teknova's Return on Capital Employed stood at 34.16% in 2022, then advanced by 16 bps to 28.54% in 2023, then climbed by 17 bps to 23.72% in 2024, then rose by 27 bps to 17.31% in 2025, then increased by 0 bps to 17.31% in 2026.
- Business Quant data shows TKNO's Return on Capital Employed at 17.31% in Q1 2026, 17.31% in Q4 2025, and 17.62% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 6.60% |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 17.16% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 6.07% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 22.04% |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -0.29% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 18.67% |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 5.52% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Alpha Teknova | 396.90 Mn | 379.46 Mn | 4.89 Mn | -17.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -17.49% |
| Mar 31, 2026 | -17.31% |
| Dec 31, 2025 | -17.31% |
| Sep 30, 2025 | -17.62% |
| Jun 30, 2025 | -20.24% |
| Mar 31, 2025 | -21.15% |
| Dec 31, 2024 | -23.72% |
| Sep 30, 2024 | -28.52% |
| Jun 30, 2024 | -29.55% |
| Mar 31, 2024 | -29.41% |
| Dec 31, 2023 | -28.54% |
| Sep 30, 2023 | -30.63% |
| Jun 30, 2023 | -49.14% |
| Mar 31, 2023 | -38.24% |
| Dec 31, 2022 | -34.16% |
| Sep 30, 2022 | -25.29% |
| Jun 30, 2022 | -12.33% |
| Mar 31, 2022 | -10.47% |
| Dec 31, 2021 | -7.50% |
| Sep 30, 2021 | -3.92% |